These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20329562)

  • 1. [A novel innate antiviral factor-tetherin].
    Yang YS; Wang XL; Li ZL; Zeng Y
    Bing Du Xue Bao; 2010 Jan; 26(1):71-5. PubMed ID: 20329562
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV/AIDS: virus kept on a leash.
    Göttlinger HG
    Nature; 2008 Jan; 451(7177):406-8. PubMed ID: 18200012
    [No Abstract]   [Full Text] [Related]  

  • 3. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.
    Rong L; Zhang J; Lu J; Pan Q; Lorgeoux RP; Aloysius C; Guo F; Liu SL; Wainberg MA; Liang C
    J Virol; 2009 Aug; 83(15):7536-46. PubMed ID: 19474106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.
    Vigan R; Neil SJ
    J Virol; 2010 Dec; 84(24):12958-70. PubMed ID: 20926557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BST-2 mediated restriction of simian-human immunodeficiency virus.
    Ruiz A; Lau D; Mitchell RS; Hill MS; Schmitt K; Guatelli JC; Stephens EB
    Virology; 2010 Oct; 406(2):312-21. PubMed ID: 20708210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of a high-throughput screening assay for interaction inhibitor between BST-2 and Vpu].
    Pang XJ; Hu SQ; Zhang Y; Cen S; Jin Q; Guo F
    Bing Du Xue Bao; 2012 Nov; 28(6):633-8. PubMed ID: 23367562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetherin restricts direct cell-to-cell infection of HIV-1.
    Kuhl BD; Sloan RD; Donahue DA; Bar-Magen T; Liang C; Wainberg MA
    Retrovirology; 2010 Dec; 7():115. PubMed ID: 21184674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Vpu and BST-2/tetherin: enemies at the gates.
    Tokunaga K
    Curr HIV Res; 2012 Jun; 10(4):275-6. PubMed ID: 22533470
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin.
    Fritz JV; Tibroni N; Keppler OT; Fackler OT
    Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of HIV-1-host interaction: role of the Vpu accessory protein.
    Dubé M; Bego MG; Paquay C; Cohen ÉA
    Retrovirology; 2010 Dec; 7():114. PubMed ID: 21176220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses.
    Lim ES; Malik HS; Emerman M
    J Virol; 2010 Jul; 84(14):7124-34. PubMed ID: 20444900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of HIV-1 virion entrapment by tetherin.
    Venkatesh S; Bieniasz PD
    PLoS Pathog; 2013; 9(7):e1003483. PubMed ID: 23874200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
    Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
    J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.
    Tokarev A; Skasko M; Fitzpatrick K; Guatelli J
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1197-210. PubMed ID: 19929170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.
    Gupta RK; Hué S; Schaller T; Verschoor E; Pillay D; Towers GJ
    PLoS Pathog; 2009 May; 5(5):e1000443. PubMed ID: 19461879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetherin inhibits HIV-1 release by directly tethering virions to cells.
    Perez-Caballero D; Zang T; Ebrahimi A; McNatt MW; Gregory DA; Johnson MC; Bieniasz PD
    Cell; 2009 Oct; 139(3):499-511. PubMed ID: 19879838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.